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ABSTRACT
We use a computational modelling approach to explore whether it is possible to infer a tumour’s cell
proliferative hierarchy, under the assumptions of the cancer stem cell hypothesis and neutral evolution.
We focus on inferring the symmetric division probability for cancer stem cells in our model, as this is
believed to be a key driving parameter of tumour progression and therapeutic response. Given the
advent of multi-region sampling, and the opportunities offered by them to understand tumour evolutionary
history, we focus on a suite of statistical measures of the phylogenetic trees resulting from the tumour’s
evolution in different regions of parameter space and through time. We find strikingly different patterns
in these measures for changing symmetric division probability which hinge on the inclusion of spatial
constraints. These results give us a starting point to begin stratifying tumours by this biological parameter
and also generate a number of actionable clinical and biological hypotheses including changes during
therapy, and through tumour evolution.
Introduction1
The cancer stem cell hypothesis (CSCH) posits that tumours are composed of a hierarchy of cells with2
varying proliferative capacities. Under this hypothesis, a subpopulation of ‘cancer stem cells’, also termed3
tumour initiating cells (TICs), are able to self-renew through symmetric division and also to differentiate4
into tumour cells resembling transit amplifying cells (TACs) through asymmetric division (see Fig 1A),5
giving rise to the entire diversity of cells within a tumour1. The CSCH provides a conceptual framework by6
which to understand many different aspects of cancer progression, including: the occurrence of functional7
heterogeneity despite genetically identical states2–4; resistance to chemotherapy5,6 and radiotherapy7–9;8
recurrence10; and metastasis11. Despite its popularity, the CSCH has been the subject of continual debate9
and modification in order to maintain compatibility with experimental observations12–14.10
While the specifics of the CSCH are still a matter of debate, the clinical relevance of those cells with11
traits ascribed to TICs is clear. Regardless of the accepted importance of this knowledge, our ability to12
measure their dynamics in a clinical setting is lacking. In vivo measurement efforts are limited to carefully13
conducted live imaging in genetically engineered mice15, or genetic labelling and subsequent lineage14
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tracing16; while in vitro systems are better suited to the extraction of these parameters, little has been done15
to quantify them, as technically demanding single-cell lineage tracing17 is required. These experimental16
difficulties speak to the need for more theoretical work in this area, especially to propose metrics for17
quantifying proliferative parameters such as TIC symmetric division probability (Fig 1A) from clinical18
data. This is of particular importance as there is mounting evidence for the relevance of a proliferative19
hierarchy in determining response to radiotherapy18 and chemotherapy5. Further, we now know that20
certain microenvironmental factors such as hypoxia19,20, acidosis21, growth factors22, and even stromal21
cell co-operation or co-option23,24, can perturb this system.22
Several published mathematical models, taking different forms and considering different aspects of23
heterogeneity, have predicted that the evolution of a solid tumour should depend strongly on whether24
or not it exhibits a proliferative hierarchy, and on the parameters of such a hierarchy. These models25
have included spatial proliferation constraints, microenvironmental heterogeneity and selective pressures,26
and the noted differences include shape, clonal heterogeneity, rate of evolution and growth dynamics.27
Werner at al. specifically studied the differences in bulk tumour behaviour between tumours arising from28
mutant TICs and TACs25 in a non-spatial context. In a spatial context, the work of Sottoriva et al.3,2629
and Enderling et al.27,28 represent the first works in which it was shown that the parameters governing30
TAC dynamics can constrain tumour growth, and also to show that TIC-driven tumours have significantly31
different spatial growth patterns: specifically, that they exhibit ‘patchy’ growth. In none of these models,32
except Sproufsske et al.29, in which the main question centred on TAC numbers, were these differences33
studied across TIC symmetric division probabilities, which is a key parameter governing the hierarchy,34
and one that is exceedingly difficult to measure or perturb in vitro or in vivo.35
To describe the evolutionary relationship between members of a species, or larger groups of life36
forms, biologists often formulate tree diagrams that represent their specific hypotheses about relatedness.37
While tree diagrams have been in use since medieval times to describe genealogies, their use to describe38
animal species was not popularized until the early 1800s. These trees were originally made on the basis39
of gross morphological differences (or similarities) and were called phenograms or cladograms, but in40
the last few decades we have begun to define these differences based on genetic information. The field41
of phylogenetics, born in the 1980s, seeks to use objective, genetic information to build trees. When42
populations are sampled, a common method of understanding the clonal evolution is through phylogenetic43
reconstruction, a method of inferring, usually from genetic sequence similarity, the evolutionary life44
history of a given life form. This has classically been applied in scientific fields such as zoology, and it has45
become a branch of bioinformatics all of its own, even spawning a branch of discrete mathematics called46
T-theory30.47
Phylogenetics has, in the last decade, begun to be applied to cancers, giving rise to a subfield48
recently dubbed ‘PhyloOncology’ by Somarelli and colleagues31. Using phylogenies reconstructed from49
spatially separated biopsies and informatic algorithms, many aspects of tumour evolution have begun50
to be elucidated32, including the genetic heterogeneity present within a primary tumour33, the origin of51
individual metastatic tumours within the primary site34,35, and the effect of chemotherapy on primary and52
metastatic sites36,37.53
In addition to these sorts of questions, there are precedents in other fields for using phylogenetic54
information, integrated with population dynamics, a technique called phylodynamics38, to infer other55
underlying biological processes. For example, Leventhal et al.39 proposed that the phylogenetic tree56
contains a ‘fingerprint’ that can be used to determine the evolutionary process driving the population in57
question. Modelling the spread of HIV within a contact network, the authors investigated whether the58
network structure could be inferred from the resulting disease phylogenies. To address this question, the59
authors simulated a range of epidemics on several families of random graphs and measured the resulting60
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phylogenetic trees, finding that certain tree-based measures could discriminate between the qualitatively61
different families of random graph structures considered.62
We hypothesize that a similar approach could be used to discriminate between in silico tumours with63
different symmetric division rates. To test this hypothesis, here we study the effect of TIC symmetric64
division probability on tumour evolution using a computational modelling approach. We focus on65
observed patterns in reconstructed phylogenetic trees across a range of symmetric division probabilities.66
The estimation of this proliferative parameter from clinical data could help improve our understanding of67
the effect of therapies on tumour growth dynamics, and our ability to stratify tumours for consideration of68
different therapies. In this way, we seek to provide translatable measures to aid in understanding tumour69
biology: to use mathematical modelling to ‘see the invisible’.70
The remainder of this paper is structured as follows. We first present a spatial stochastic model71
of tumour growth under a proliferative hierarchy with neutral mutations, which we embed on a two-72
dimensional lattice to enable the study of the effect of spatial constraints. Next, we develop an algorithm73
to reconstruct the branched phylogenetic structure from each realization of our tumour growth model. We74
apply a range of statistical measures of phylogenetic tree shape to simulation outputs for comparison. We75
explore the temporal dynamics of these measures over the course of tumour growth to assess whether they76
are robust to tumour size changes, and then to changes in mutation frequency. Finally, we discuss the77
possible clinical utility of these measures.78
Materials and Methods79
Model development80
Here, we describe the development of a two-dimensional, lattice-embedded cellular automaton (CA) model81
of tumour growth with contact inhibition growing under neutral evolution and a proliferative hierarchy.82
Proliferative hierarchy83
We model a proliferative hierarchy comprising two cell types, TICs and TACs. We assume that each84
TIC divides symmetrically with probability α , creating two TICs, and asymmetrically with probability85
1−α , creating one TIC and one TAC. While there is evidence that microenvironmental parameters such86
as nutrient deprivation40, acidity21 and hypoxia41,42 can change symmetric division probability, and that87
it is likely to vary from cell to cell, for simplicity we will assume it is constant. As it has been shown88
theoretically that the overall population dynamics of TIC-driven tumours is equivalent with or without89
TIC symmetric differentiation43 (when a TIC divides to create two TACs), and as the lineage extinction90
possible in this case would significantly complicate our phylogenetic analysis, we make the simplifying91
assumption that there is no symmetric differentiation. We do not rule out that the addition of symmetric92
differentiation could affect phylodynamics, but leave that question for further study.93
We assume that every TAC division is symmetric, creating two TACs, but only allow this to progress94
for β rounds of division, after which the TAC will die if chosen to divide again. Here β represents the95
replicative potential of TACs, and is posited to represent telomere length44. Previous theoretical work96
has shown that tumour growth kinetics in spatially constrained geometries are strongly affected by the97
value of β 28. In particular, if β > 5, then simulated tumours experience unrealistically lengthy growth98
delays. Therefore we follow a previously used assumption3,29 and fix β = 4. This mode of growth and99
differentiation is illustrated in Fig 1A. For simplicity, we neglect cell death, though this could be added as100
a straightforward extension in future work.101
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Figure 1. Spatial stochastic model schematic with neutral mutation schema. (A) The proliferative
hierarchy. Each TIC can divide symmetrically with probability α to make two identical TIC progeny, or
asymmetrically with probability (1−α) to make one TIC and one TAC. TACs divide symmetrically until
they reach a specific divisional age (β = 4 for this work), after which they die upon division attempt. (B)
At each division event (branching) after the first (carcinogenesis, labelled with a 1), a random number of
mutations drawn from a Poisson distribution with expectation λ is conferred on each daughter
(subsequent starred events). Each mutation event is given a unique flag, which is inherited by its offspring
unless they too mutate. Each unique mutation can then be considered as a novel mutant allele (red)
appearing in the population. (C) Flowchart outlining cellular automaton rules governing TIC and TAC
growth, including spatial inhibition of growth and TAC age.
Neutral evolution102
To understand the effects of neutral evolution on tumours with differing proliferative hierarchies, we103
extend our model of tumour growth under a proliferative hierarchy to include random mutations. At104
each cell division, there is a possibility that one or more mutations occur. To determine the number of105
mutations accumulated by a given daughter cell, we independently draw a random number from a Poisson106
distribution with rate λ . We assume for simplicity that every mutation arising in our model is unique. This107
‘infinite sites’ assumption is usually ascribed to Kimura45.108
For simplicity, we assume that mutations confer no advantage, disadvantage or any other phenotypic109
change and therefore serve only as a method by which to track clonal lineages. This assumption could in110
principle be loosened to allow for positive selection46, a balance of positive and negative selection47, and111
neutral evolution48. A schematic of this model of evolution, and labelling scheme, is shown in Fig 1B.112
For computational efficiency, we record a unique flag only for the most recent mutation accumulated113
within a cell, which is passed down to its progeny, unless a mutation occurs, in which case a new flag is114
assigned. We also record each mutation event in the form of an ordered pair (parent flag, child flag), so115
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that the complete ‘genomes’ (bit strings) can be reconstructed for future use. As they are the only cells116
capable of forming tumours on their own, and infinite replication, we follow previous works in considering117
new mutations to accrue only in TICs3,26, 29, 49.118
Spatial dynamics119
As we are interested in the effect of the proliferative hierarchy on the neutral evolutionary process in solid,120
spatially constrained tumours, we embed our cell-based model in a two-dimensional square lattice. While121
recent work has shown some qualitative differences in vascularised CA models between two and three122
dimensions, using a two-dimensional lattice for unvascularised tissue is a common simplification50–53 that123
allows spatial constraints to be studied in a computationally tractable manner. In addition to the above124
description of cell proliferation, we consider cell proliferation to be modulated by contact inhibition54.125
Each cell is allowed to divide only if there is one or more free lattice sites within that cell’s Moore126
neighbourhood; if not, then we consider the cell to be in a quiescent state that may be exited when space127
becomes available. At each time step, each ‘cell’ has an opportunity to divide given that it has space to do128
so. Cells are chosen uniformly at random for updates from the entire population to avoid order bias.129
Cell-type specific rules130
If space is available, and the cell is a TIC, then the type of division is determined by choosing a uniform131
random number, r, from [0,1]. If r < α , then the TIC divides symmetrically, creating another TIC that is132
Figure 2. Temporal evolution of the spatial model reveals observable morphologic differences
between TIC-driven and non-TIC-driven tumours, as observed by others. We plot representative
results of simulations of two tumours, each simulated on a square lattice of size 400×400. Top: a tumour
simulated with α = 0.2 and β = 4. We notice, as have Enderling et al.27 and Sottoriva et al.3, a ‘patchy’
clonal architecture, and non-uniform edge. Bottom: a tumour simulated with α = 1.0, i.e. no proliferative
hierarchy. We note smooth edges, radial patterns of clonal architecture and relatively faster population
growth, reaching ≈ 70,000 cells in less than 200 time steps. To reach a similar size, the tumour with
symmetric division probability of 0.2 took 35,000 time steps. Colour bars denote number of mutations
present in a given clone, note that the top scale is about 1/3 of bottom scale.
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placed uniformly at random in one of the free neighbouring lattice sites. The parent and daughter TICs133
will independently acquire a random number of new mutations, as described above. If r ≥ α , then the TIC134
divides asymmetrically, creating a TAC that is placed uniformly at random in one of the free neighbouring135
lattice sites. The daughter TAC is created with the same mutation ID as the parent, and age = 0, while the136
parent TIC will independently acquire a random number of new mutations, as described above.137
If the chosen cell is instead a TAC, then the check after available space is a check of the cell’s138
proliferative age, which is the number of divisions as a TAC. If the TAC age is equal to the replicative139
potential, β , then the TAC dies, at which point it is removed from the simulation. If the TAC age is less140
than β , then we create a new TAC daughter and place it in an empty space in the Moore neighbourhood at141
random. The parent and daughter TACs share the same mutation ID and their age is updated to be one142
more than the age of the originally chosen TAC.143
Full implementation144
The full CA flow-chart, represented in Fig 1C, schematises the entire process of cell fate decisions that145
each cell undergoes at each time step in the spatial model. In the top panel, the rule set followed by the146
TICs is represented to include differentiation and mutation. In the bottom panel, the TAC rule set is defined147
to include death by terminal differentiation and TAC aging. An example simulation of tumor growth over148
time is shown in Fig 2, where the effect of lowering α can be seen on overall tumour growth kinetics,149
where the colour-bar represents the current clonal state (mutation ID) of a given clone.150
Recovering phylogenetic trees from simulation151
While experimentalists and clinicians can only infer phylogenies from incomplete data, reconstruction of152
the ‘true’ phylogeny is possible in our model as we can record the entire life history of the simulated tumour.153
Thus, we can test whether phylogenetic tree-based measures are able to discriminate TIC symmetric154
division probability in the case where the ‘ground truth’ is known. At each time step we record the spatial155
location of each individual cell with its mutation ID, which is our CA state vector. Additionally, we record156
the evolutionary ‘life history’ as a list of ordered pairs of every mutation event (parent mutational ID, child157
mutational ID). We then recursively construct the phylogenetic tree from this life history.158
Phylogenetic tree reconstruction algorithm159
To create the complete tree data structure required for our quantitative analyses we use the information160
encoding the mutation events from our stochastic simulation. To this end, we create a list of unique161
parent-child pairs using the life history of mutation events. We then apply an iterative process in which162
each child is added as a subnode below the parent (from the unique parent-child pair). This process is163
continued until all parent-child pairs are added to the structure, and the tree is complete. The simulation164
code and functions to create these trees and calculate the metrics is freely available on request.165
Qualitative comparison of reconstructed trees166
To compare phylogenies from simulations with different underlying parameter values, we first construct167
and visualize the phylogenies constructed from three example simulations with differing TIC symmetric168
division probabilities in Fig 3. It is clear by inspection that the number of mutations increases with169
symmetric division probability (more branches). However, the tree structure is not as easy to parse visually.170
For ease of visualization the trees depicted in Fig 3 have been pruned of all terminal nodes (also called171
leaves) with no children of their own. While this transformation does affect the quantitative results, it does172
not qualitatively affect the resultant phylogenetic tree statistic ranks (see Fig 8). All analyses shown will173
utilize the full trees.174
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Figure 3. Three example simulations with increasing symmetric division probability, α (0.2, 0.6
and 1.0 from top to bottom) and their associated phylogenetic trees. Each example plot is the result
of a single stochastic simulation of our spatial CA model. Each simulation is initiated with a single TIC
and complete when the domain is full, in this case 250,000 cells. Parameter values are β = 4 and
λ = 0.01. Visualized trees (right) have been pruned of all leaves for ease of visualisation, which does not
qualitatively affect measure rank (see Fig 8).
Candidate tree-based measures for model comparison175
Visual inspection of Fig 3 suggests that simulations with different TIC symmetric division probabilities176
generate distinct phylogenetic trees. However, to make meaningful conclusions we must perform a177
quantitative comparison. Here we present several measures useful in summarising and comparing178
phylogenetic trees. The most commonly studied property of a phylogenetic tree’s shape is its balance,179
defined as the degree to which internal nodes (branch points) have the same number of children as one180
another. Balance (or imbalance) indices depend only on the branching topology of trees, and not on181
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other factors like branch length or other features of the terminal branches (leaves). Since the first balance182
index by Sackin55, many others have been proposed with slightly differing properties56. One of the first183
papers to present a systematic comparison of a suite of balance indices (often denoted with the letter ‘B’)184
and indices of imbalance (denoted with ‘I’) was by Shao and Sokal57, who reported striking differences185
between the studies’ measures. Their central message was that different measures on trees can give186
insight into different aspects of the underlying processes governing the interactions, and one should thus187
consider several measures for any given tree or family of trees. In this study we will consider several tree188
topology-based measures.189
Before describing the measures, it is worthwhile to briefly define the terms which are used to describe190
trees, and the two basic underlying stochastic models which have been proposed to describe neutral191
evolution and the resulting topologies. Phylogenetic trees are mathematical objects which describe the192
evolutionary relationship between individuals with different physical traits from one another, or in the193
case of our model, different mutational combinations (genotypes). In our model, each simulation begins194
with a cell with mutation flag 1, or a genotype with the first allele mutated (1000...), termed the ‘root’, and195
evolution progresses stochastically, by adding individual mutations at subsequent alleles and increasing196
the mutation flag, as described in Fig 1B. At each mutation event, an evolutionary branch point is created,197
which is termed a node in phylogenetic tree terminology. If this node gives rise to no other children during198
the simulation, it is termed a terminal node, or leaf. There are two common, classically referenced models,199
which bear mention here as well, since many tree topology-measures are normalized against them. The200
first, described by Yule in 192458 and sometimes termed the ‘equal rate Markov’ model, begins with a201
single root and proceeds by replacing, uniformly at random, a given leaf with a node with two children of202
its own. The process continues until the desired number of leaves exist. The other main model, termed the203
‘Proportional to Distinguishable Arrangements’ or uniform model, was described by Rosen59. This model,204
which is truly a model of tree growth rather than an explicitly evolutionary process, begins as does the205
Yule model (and indeed ours) with a single node labelled 1. At each update step, a new leaf is added to the206
tree at any point, either internal node or leaf. These models will serve as normalisation factors in several207
of the measures we present below, which are summarised graphically in Fig 4.208
Sackin index209
The Sackin index was the first statistic used to understand the balance of a phylogenetic tree55,57. To
compute this statistic, one sums the number of ancestors (Ni) for each of the n terminal nodes of the tree:
Ins =
n
∑
i=1
Ni. (1)
This index increases with tree size: under the Yule growth model, its expectation E[Ins ] grows as 2n logn
58.210
One can therefore only perform a meaningful comparison of Sackin indices of trees generated from211
tumours if they are the same size.212
Normalized Sackin index213
To address this dependence on tree size, several normalisations to the Sackin index have been proposed,
two of which we explore here. In particular, one can normalise the Sackin index of a phylogenetic tree to
the expectation value of a similarly sized tree, under the Yule growth model:
IYule =
1
n
(
Ins −2n
n+1
∑
j=2
1
j
)
. (2)
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One can alternatively normalise using the Proportional to Distinguishable Arrangements (PDA) model59–61214
which is simply the Sackin index scaled by n3/2.215
The B1 statistic216
The B1 statistic, originally described by Shao and Sokal57, considers the balance of a tree. To calculate
the measure, one uses all i internal nodes of the tree with the exception of the root (the founding cell). For
each non-root internal node j, the maximum number of nodes traversed along the longest possible path to
a terminal node, M j, is counted. The B1 statistic is then defined as
B1= ∑
i
1
M j
∀i 6= root. (3)
N¯217
N¯ reports the average number of nodes above a terminal node. To compute this, we sum the path from218
each terminal node to the root, and divide by the number of terminal nodes. An alternative definition is the219
Sackin index ‘normalised’ by the number of terminal nodes. For a more complete review and comparison220
of the measures presented here, and others, see Blum et al.62 and Shao and Sokal57.221
Examples of how these measures change on several example trees with equal numbers of leaves (but222
different numbers of internal nodes) are presented in Fig 4. In these examples, we compute each of223
the presented measures for comparison. From left to right, the trees contain 4, 3 and 2 internal nodes224
respectively, but the same number (6) of leaves. We note that the measures do not all follow the same225
pattern. For an exhaustive description of all possible trees with 6 leaves, and the correlation of a larger226
family of associated measures, see Shao and Sokal57.227
Results228
Measuring trees from simulation229
As our primary goal is to identify whether tree-based measures allow discrimination of simulated tumours230
with different TIC symmetric division probabilities, we focus on changes in tree measures as we vary231
comparable simulations changing only this parameter. To compare the model tree measures, we first232
Figure 4. Example phylogenetic trees and their measures. From left to right the trees contain 4, 3
and 2 internal nodes (dots) respectively, but the same number (6) of terminal nodes.
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perform 50 stochastic simulations of our spatial CA using a range of TIC symmetric division probabilities233
(0.2,0.4,0.6,0.8 and 1.0), holding mutation rate and TAC lifetime constant (λ = 0.01 and β = 4). For234
each simulation, we construct the resulting phylogenetic tree at tumour size 250,000 cells, as described in235
the Materials and Methods section. We then measure the value of each summary index defined earlier for236
all 50 simulations at the final time point and plot the distribution in a box-whisker plot, which is shown237
in Fig 5 with each data point overlaid in a swarm. Differences between distributions were determined238
using the Wilcoxon rank sum test. While these statistics were performed post hoc, we should note that239
standard statistics can be misleading for simulation based studies with arbitrarily large sample sizes63 (see240
Supplementary Fig 9 for effect size).241
Variation of tree-based measures with symmetric division probability242
The results of the model are presented in Fig 5. We find that all of the indices have monotone relationships243
with symmetric division probabilities except for N¯. Of the normalised indices, the B1 statistic has the244
least overlap in error between symmetric division probabilities. All measure distributions are significantly245
different by the Wilcoxon rank sum test (p< 0.05) except 0.4 and 0.6 in the Sackin index normalised by246
the Yule model (p = 0.08). While we recognize the dangers in reporting p-values in simulation based247
studies 63, we report them here for comparison, and report effect size as well, with full statistics reported248
in Figure 9. The strongest effect is seen in the Sackin index (R2 = 0.871), followed closely by the Yule249
normalised Sackin index (R2 = 0.743).250
Figure 5. A summary of four tree indices measured over a range of symmetric division
probability. We plot the distribution of each of four measures of tree balance for the final resultant trees
from 50 simulations against symmetric division probability. All simulations were run with β = 4 and
λ = 0.01 until a tumour size of 250,000 cells. In each plot we display a box-whisker plot as well as the
individual results as points. NS = non-significant by the Wilcoxon rank sum test.
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Dynamics of tree-based measures during tumour growth251
As discussed in Materials and Methods, the measures considered here are strongly dependent on the total252
number of nodes in the tree. With all other parameters held constant, simply allowing a tumour to grow253
larger would increase the number of total mutations, and therefore the number of total nodes, subsequently254
altering the value of the measure. To ensure that the differences we have noted are robust to changing255
tumour size, we next consider how these measures evolve during the growth of a tumour.256
Figure 6. Comparing phylogenetic tree measures across symmetric division probability through
tumour growth. We plot the average and standard deviation (error bars) of four phylogenetic tree
measures for each of the 50 simulations for a range of symmetric division probabilities over the course of
tumour growth. Rank is maintained across symmetric division probabilities for each of the 3 tree
measures with which we could discriminate between symmetric division probabilities. As before, N¯ is not
predictive and changes rank throughout tumour growth. All tumours are grown to eventual confluence at
250,000 cells. In all simulations β = 4 and λ = 0.01.
To determine how these measures vary over the life of a growing tumour, we measure the index257
over the course of each simulation at increasing tumour sizes. To accomplish this, we use the life258
history to reconstruct the tree at 20 equally spaced time points during the lifespan of each of the 50259
simulations for each symmetric division probability. The time to fill the domain for each of the symmetric260
division probabilities is quite different as the dynamics of tumours driven by differing symmetric division261
probabilities are different (see Fig 2). So, we break the life history into equally spaced time intervals, as262
the total times in each family of simulations are different. When we compare across symmetric division263
probabilities we need to consider this ‘time’ to be a surrogate for tumour size instead instead of explicitly264
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comparing times. Comparing across tumour size is of greater utility clinically, however, as the age of a265
given tumour is rarely known, while size can be readily approximated.266
After reconstruction, we then create a ‘time’ trace for each statistic. We plot these statistics over267
‘time’ in Fig 6, where each family of 50 simulations (for a given symmetric division probability) is268
represented by a single trace with the standard deviation represented by the coloured error bars. We find269
that for each of the statistics, except N¯, the relationships between the symmetric division probabilities are270
maintained over time, suggesting that, if we know the tumour size, and true phylogeny, we can estimate the271
relative symmetric division probability between two samples from these measures. This statement must272
be somewhat qualified by the fact that mutation probability was also held constant for these simulations.273
While estimating mutation probability is not trivial, significant advances have been made in measuring274
the speed of the ‘evolutionary clock’ of tumours: essentially a proxy for mutation probability64. Further,275
we found that the rank order of each discriminatory measure holds throughout tumour growth, indeed276
becoming more discriminatory as the tumours grow larger (with the exception of N¯). As the tumours277
simulated in this study are unrealistically small given the computational constraints, this information278
gives us hope that in tumours of realistic size, these measures would be even more useful. This becomes279
particularly important as the statistics that we have calculated come from the ‘true trees’, that is, trees280
comprised of all mutation events. In reality, trees would be inferred from the imperfect information281
gleaned from biopsies.282
Dependence of tree-based measures on mutation probability283
As the tree measures depend heavily on the number of mutations within a given tumour, and therefore the284
number of branches within a given tree, we next ask how these measures behave when we vary mutation285
probability (λ ) and symmetric division probability simultaneously. To answer this, we perform 10286
stochastic simulations for each combination of the symmetric division probabilites considered previously287
and 5 different values for λ varying over two orders of magnitude (0.001,0.005,0.01,0.05,0.1). We then288
use the previously described method to reconstruct the resulting phylogenies and calculate the measures289
previously discussed. In particular, we ask how the Sackin index, the B1 statistic and the normalized290
Sackin index perform over this range of λ to better understand the applicability of these measures in291
determining differences in symmetric division probability.292
We plot the results of this parameter investigation in Fig 7. In each heat map, we plot the mean of293
the 10 simulations for each parameter combination with symmetric division probability varied along the294
horizontal axis and mutation probability along the vertical. The indices which are not normalized by295
branch number, namely the Sackin index and B1 statistic, increase monotonically with mutation probability296
and symmetric division probability in all cases. The Sackin index normalised by the PDA model, however,297
varies somewhat unexpectedly and has a global minimum at symmetric division probability of 1.0 and298
mutation probability 0.01. This measure is monotonic in symmetric division probability except at the299
highest mutation probability where it becomes somewhat more difficult to determine the differences.300
As before, the B1 statistic appears to be the most stable, and only breaks down slightly in its ability to301
distinguish between the families of simulations at the lowest mutation probability (λ = 0.001) and the302
middle range of symmetric division probability (symmetric division probabilities = 0.4−0.8), as can be303
seen in Fig 7.304
Discussion305
While the use of phylogenetic trees is increasing in translational oncology laboratories, there has yet to be a306
method found by which we can utilise the information clinically. To address this shortcoming, we worked307
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Figure 7. Comparing phylogenetic tree measures across symmetric division probability and
mutation probability. We plot the average of each of four phylogenetic tree measures at the end of each
of 10 simulations for a range of symmetric division probabilities and mutation probabilities. We vary
mutational probability over two orders of magnitude (0.1−0.001), and simulate all tested symmetric
division probabilities. Rank is maintained across symmetric division probabilities for each of the three of
the four measures with which we could discriminate between symmetric division probabilities with
changing mutation probability, allowing for differentiation between parameters. As before, the N¯ statistic
is not predictive. As expected, for the non-normalized indices, Sackin and B1, the measures change
monotonically with both symmetric division and mutation probability. For the PDA normalized Sackin
index, however, there is a global minimum for λ = 0.01 and α = 1.
to leverage the growing interest in biomarker derivation from spatially distinct tumour biopsies65, and308
the recent success of Leventhal39 and others in teasing apart complex biological rules from phylogenetic309
information. We developed an individual based model of tumour growth under a TIC driven proliferative310
heterogeneity which undergoes neutral evolution. We then developed an algorithm to construct phyloge-311
netic trees from simulated tumours. The resultant trees were then analysed and compared using a suite312
of statistical measures of tree (im)balance. Through this method, we have generated a large dataset that313
includes the observed statistical measures of the ‘true’ phylogeny for tumours with a range of symmetric314
division probabilities.315
In particular, we compared the classical measures of tree topology – the Sackin index and the B1316
statistic – as well as normalized versions of each across several parameters of our spatial and non-spatial317
models as well as through the process of tumour growth. Not surprisingly, we found that the Sackin318
index was able to discriminate between the families of simulations as it is directly correlated with branch319
number (in this case correlating with total number of mutations in the TICs, which also is increased with320
increasing symmetric division probability). Encouragingly, we also found that the normalised version of321
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this metric was able to discriminate between the different symmetric division probabilities, suggesting322
a more meaningful (and measurable) topologic difference between the underlying phylogenetic trees323
resulting from these parameter changes (representing diverse biological traits).324
While we have shown that these measures differ significantly from one another, we have not yet325
provided a method by which we can use the metric of a given tree to directly predict the symmetric326
division probability of an unknown tumour. However, the present work at least allows us to understand327
the rank order of symmetric division rate for two tumours given their measured indices. This could be328
particularly useful in certain clinical settings. For example, this could allow us to determine how a given329
therapy affects symmetric division probability by using our calculated measures over serial biopsies, and330
subsequent phylogenetic reconstruction.331
Conclusions332
Aiming towards a translatable method by which to infer the symmetric division probability in solid333
tumours, we have identified several phylogenetic tree based measures that correlate with TIC symmetric334
division probability. We have found several measures which are able to discern differences in simulated335
tumours between symmetric division probabilities. These results are robust to changes in tumour size,336
specifically maintaining their rank throughout tumour growth. The rate of mutation does affect these337
results to some degree, but rank is maintained permitting comparison through time, or between tumours of338
similar size.339
While there is some overlap amongst the measures when more than one parameter is varied, with340
information on mutation probability and tumour size, relative symmetric division probability can be341
estimated. we have only restricted our focus to measures of (im)balance, a basic property of phylogenetic342
trees based only on their branching topology. With more information, such as evolutionary branch343
lengths66,67 which are linked to the ‘speed’ of a tumour’s molecular clock64, some of these limitations could344
be obviated. Further, we have only considered neutral evolution. While most tumour evolution is likely345
neutral48, there is certainly evidence for non-neutrality in the form of driver and passenger mutations47,68,346
which would drastically affect the resulting phylogenetic trees38 – especially with intervening treatment347
regimens. How non-neutral evolution and treatment affect our measures remain avenues for future work.348
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Supplemental Material487
Pruning trees does not affect rank of statistics488
To visualize the trees more easily in Fig 3, we prune the leaves from each full tree. While this changes the489
absolute value of each of the tree-based measures, it does not affect their relative ranking. This suggests490
that each measure is capturing something fundamental about the biology as it appears invariant with tree491
size. This is corroborated by the results shown in Fig 6, indicating that the rank of each measure is stable492
over tumour growth.493
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Figure 8. Raw and pruned trees give rise to qualitatively similar summary measures with rank preserved. For each tree-based
measure considered in the main text, we plot the measure based on the full (upper) and pruned (lower) tree. For each pair, we plot the results
from 10 simulations for each of the tested symmetric division probabilities. From left to right, we plot the B1 statistic, N¯, the Sackin index,
the PDA normalised Sackin index and finally the Yule normalised Sackin index.
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Effect size of symmetric division probability494
To better understand the impact of the symmetric division probability on changes in results tree topology,495
rather than just use differences between families of simulations, we compute the regression slope, R2496
and p-value of the regression line for each case. For the B1 statistic we find a regression slope of497
142.64, R2 = 0.72, p = 1.74× 10−71. For the Sackin index we find a regression slope of 5178.61,498
R2= 0.871, p≈ 0. For the Yule normalised Sackin index we find a regression slope of−2.380, R2= 0.743,499
p = 3.25× 10−75. For the N¯ statistic we find a regression slope of −0.111, R2 = 0.0075, p = 0.172.500
These values are plotted in Fig 9.501
Figure 9. Effect size of symmetric division for four tree-based measures. We plot the effect size for
the data shown in Fig 5.
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Algorithm for generating individual cell ‘genomes’ from mutational flag and life history502
Here we describe the algorithm we created to develop the individual cells ‘genomes’ from the mutational503
flag and the life history. Using this reconstruction algorithm allows for significant increase in speed of our504
tumour growth model and reduced memory requirements by several orders of magnitude.505
Algorithm 1: Pseudo-code describing algorithm to reconstruct genomes from unique mutation flags
and family history.
Data: Dictionary of unique Parent:Child pairs and spatial array of unique mutation flags at time
point of interest.
Result: Array of bitstrings representing ‘genomes’ of cells in array.
for All cells in array do
if mutation ID = 0 then
break
end
set bitstring to ’1’ + maxval(mutation ID) ’0’;
final-parent = 2;
if mutation ID = 1 then
finalize bitstring
end
while final-parent > 1 do
final-parent = lookup parent(cell of interest) in dictionary;
flip bitstring at position(cell of interest) to ’1’;
end
finalize bitstring;
end
22/22
.CC-BY-NC 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/334946doi: bioRxiv preprint first posted online May. 30, 2018; 
